Hair loss is not inevitable with chemotherapy. Your treatment drugs and doses affect the risk. This guide explains what to expect and what to ask your care team.
Could a Blood Test Help Doctors Choose the Right Cancer Treatment?
Research Explained
A blood sample. More clues about treatment.
Researchers are exploring whether signals in blood could help predict
who benefits from immunotherapy. The findings are encouraging,
but the test remains experimental.
Could a blood test help doctors choose the right cancer treatment?
Research from Stanford Medicine and Mayo Clinic suggests a possible new
approach: looking beyond cancer cells to understand the cells surrounding them.
[Reference 1]
The study was published in Nature on May 6, 2026.
It offers evidence for a developing testing method, rather than proof
that the method already improves treatment decisions.
Why Look at the Cells Around a Tumor?
Cancer cells share their surroundings with immune cells, support cells
and blood vessels. Together, these form the tumor’s
microenvironment — its local neighborhood.
These neighbors can influence how a cancer behaves and responds to treatment.
Studying their patterns may reveal information that cancer cells alone
cannot provide.
[Reference 2]
In Plain Language
The surroundings matter, too.
Think of studying a plant and the soil around it. Understanding both
may explain more than examining the plant alone.
This is an analogy for the research, not a description of how cancer grows.
How Could a Blood Test Help Choose Cancer Treatment?
Researchers identified nine recurring cellular patterns within tumors.
They then developed a computational method to estimate these patterns
from chemical markings on DNA fragments circulating in blood.
These markings, called DNA methylation, provide clues
about the cells the DNA came from. The approach uses machine learning
to interpret those clues.
[Reference 1]
What Did the Research Find?
NIH’s explanation highlights an analysis of blood samples from
78 people with melanoma receiving immune checkpoint
inhibitors, a type of immunotherapy.
Some cellular patterns were associated with treatment benefit and longer
survival. Another was associated with resistance and shorter survival.
These associations suggest potential value for predicting treatment response.
[Reference 2]
What Research Supports
Useful clues can be found in blood.
Researchers detected signals linked to the tumor environment
and observed relationships with immunotherapy outcomes.
What Remains Unproven
Better outcomes from using the test.
Predicting a response is different from demonstrating that
test-guided treatment helps patients live longer or feel better.
Was the Blood Test Proven in More Than 1,300 Patients?
Mayo Clinic describes wider analyses involving more than 1,300 patients
across several cancers. That number should not be interpreted as
1,300 people all receiving this experimental blood test.
The research combined different datasets and methods.
The blood-based melanoma analysis described by NIH was a smaller
part of that work.
[Reference 2]
[Reference 3]
Can Patients Get This Test Now?
Mayo Clinic describes the technology as investigational.
Researchers are continuing validation in larger patient populations
and exploring additional treatment applications.
[Reference 3]
Practical Caution
Do not change treatment because of this headline.
This research does not justify starting, stopping or switching treatment
on your own. Ask your cancer care team which established tests
are relevant to your diagnosis.
What Could This Mean in the Future?
A blood-based approach could make repeated assessment easier than
repeated tissue sampling. The aim is to help doctors understand
treatment response and how tumor biology changes over time.
Whether this particular method can reliably guide care across different
cancers still requires further clinical validation.
[Reference 3]
Key Takeaways
- The research examines the tumor’s surroundings through signals in blood.
- Early findings connect certain patterns with immunotherapy outcomes.
- The blood-based findings should not be generalized to every cancer.
- The test remains experimental.
Related CancerSnoop Articles
CancerSnoop Bottom Line
A promising direction. Further validation needed.
A blood test that helps match patients with treatment would be valuable.
This research moves toward that goal, while leaving important
questions about everyday clinical use unanswered.
Scientific Sources
Reference 1 — Non-invasive profiling of the tumour
microenvironment with spatial ecotypes
Zhang W, Brown EL, Usmani A, et al.
Nature. 2026;654:1076–1087.
Published online May 6, 2026.
DOI: 10.1038/s41586-026-10452-4. PMID: 42092150.
Reference 2 — Blood test predicts tumor response to treatment
Brian Doctrow, Ph.D. NIH Research Matters.
National Institutes of Health. June 2, 2026.
Reference 3 — New blood test may predict immunotherapy response
Mayo Clinic. June 25, 2026.
Source transparency:
The NIH and Mayo Clinic pages explain the same Nature study.
These are three sources, not three independent studies confirming the test.
Evidence last checked: October 25, 2026.
This article provides educational information and does not replace
advice from your cancer care team.
This article provides educational information and does not replace
advice from your cancer care team.
Continue Exploring
